Literature DB >> 22115966

Induction of IGF-1R expression by EGR-1 facilitates the growth of prostate cancer cells.

Yang Ma1, Qinqin Cheng, Zijia Ren, Lu Xu, Ying Zhao, Jie Sun, Siyi Hu, Weihua Xiao.   

Abstract

The transcription factor Early Growth Response-1 (EGR-1) is overexpressed in human prostate tumors and contributes to prostate cancer progression through an unknown mechanism. Here we report that EGR-1 transcriptionally regulates the expression of insulin-like growth factor-1 receptor (IGF-1R), which is highly expressed in primary prostate cancer. We find that ectopic expression of EGR-1 causes increase in IGF-1R expression, while knockdown of EGR-1 leads to dramatically decrease in IGF-1R expression. Results from chromatin immunoprecipitation (ChIP) and reporter assay show that the EGR-1 directly binds to the human IGF-1R gene and triggers the target gene expression. EGR-1 activates Erk and Akt pathway through regulation of IGF-1R, and thus promote prostate cancer cell growth. Taken together, these results suggest that EGR-1 may stimulate prostate cancer cell growth through up-regulation of IGF-1R and indicate that down-regulation of EGR-1 could be an effective therapeutic approach against prostate cancer.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22115966     DOI: 10.1016/j.canlet.2011.11.021

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

Review 1.  Prostate cancer: the need for biomarkers and new therapeutic targets.

Authors:  Juliana Felgueiras; Joana Vieira Silva; Margarida Fardilha
Journal:  J Zhejiang Univ Sci B       Date:  2014-01       Impact factor: 3.066

2.  Micellar delivery of flutamide via milk protein nanovehicles enhances its anti-tumor efficacy in androgen-dependent prostate cancer rat model.

Authors:  Ahmed O Elzoghby; Maged W Helmy; Wael M Samy; Nazik A Elgindy
Journal:  Pharm Res       Date:  2013-06-06       Impact factor: 4.200

3.  Clinicopathological implications of GNAS in Ewing sarcoma.

Authors:  Byeong-Joo Noh; Ji-Youn Sung; Youn Wha Kim; Eduardo Santini Araujo; Ricardo Karam Kalil; Woon-Won Jung; Hyun-Sook Kim; Yong-Koo Park
Journal:  Oncol Lett       Date:  2016-05-05       Impact factor: 2.967

4.  MicroRNA-495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin-like growth factor receptor-1.

Authors:  Ying Ye; Juhua Zhuang; Guangdong Wang; Saifei He; Suiliang Zhang; Guoyu Wang; Jing Ni; Jiening Wang; Wei Xia
Journal:  Exp Ther Med       Date:  2017-11-08       Impact factor: 2.751

5.  The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK⁺ T-cell lymphoma.

Authors:  Deeksha Vishwamitra; Choladda V Curry; Serhan Alkan; Yao-Hua Song; Gary E Gallick; Ahmed O Kaseb; Ping Shi; Hesham M Amin
Journal:  Mol Cancer       Date:  2015-02-25       Impact factor: 27.401

6.  Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells.

Authors:  Tanushree Chatterji; Andreas S Varkaris; Nila U Parikh; Jian H Song; Chien-Jui Cheng; Rebecca E Schweppe; Stephanie Alexander; John W Davis; Patricia Troncoso; Peter Friedl; Jian Kuang; Sue-Hwa Lin; Gary E Gallick
Journal:  Oncotarget       Date:  2015-04-30

7.  Repression of phosphoinositide-dependent protein kinase 1 expression by ciglitazone via Egr-1 represents a new approach for inhibition of lung cancer cell growth.

Authors:  Swei Sunny Hann; Qing Tang; Fang Zheng; Shunyu Zhao; Jianping Chen; ZhiYu Wang
Journal:  Mol Cancer       Date:  2014-06-13       Impact factor: 27.401

8.  PINCH-1 promotes IGF-1 receptor expression and skin cancer progression through inhibition of the GRB10-NEDD4 complex.

Authors:  Xiaoxiao Wang; Rong Wang; Kun Jiang; Maohua Zhu; Ling Guo; Chuanyue Wu
Journal:  Theranostics       Date:  2022-02-28       Impact factor: 11.600

9.  High expression level of CXCL1/GROα is linked to advanced stage and worse survival in uterine cervical cancer and facilitates tumor cell malignant processes.

Authors:  Xiaxia Man; Xiaolin Yang; Zhentong Wei; Yuying Tan; Wanying Li; Hongjuan Jin; Baogang Wang
Journal:  BMC Cancer       Date:  2022-06-28       Impact factor: 4.638

Review 10.  Biological and biomedical functions of Penta-O-galloyl-D-glucose and its derivatives.

Authors:  Yanyan Cao; Klaus B Himmeldirk; Yanrong Qian; Yulin Ren; Ahmed Malki; Xiaozhuo Chen
Journal:  J Nat Med       Date:  2014-02-15       Impact factor: 3.192

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.